A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

Gestational weight gain above or below the Institute of Medicine recommendations was associated with a greater risk for adverse outcomes.

Patients with gout receiving oral ULT showed similar rates of MSU crystal dissolution in the joints and tendons.

Reductions in urinary arsenic were linked to significantly lower chronic disease mortality, cancer mortality, and CVD mortality.

Favorable physician job outcomes were associated with better nurse staffing adequacy, clinical care environments, and clinician teamwork.

Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

Patients with SjD experience systemic disease activity and symptom burden that are closely tied to impaired health-related quality of life.

The ACR issued a 2025 guideline for the treatment of SLE that addressed treatment and management of specific organ system ...

The FDA has approved Osvyrti (denosumab-desu), a biosimilar to Prolia (denosumab), and Jubereq (denosumab-desu), a biosimilar to Xgeva (denosumab).

Fibromyalgia severity scores showed modest seasonal variations, with higher widespread pain reported during autumn vs summer.

Chronic headache, neck, back, abdominal, hip, and widespread pain were linked to an increased risk for hypertension.